Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Lelex Prime: ‘Decoding human thought’ could give ultimate competitive edge
You won’t find tumbleweeds blowing down Main Street, but if you look hard enough you’ll start to see Kansas City taking the shape of a new Wild West; one where tech startups like Lelex Prime have staked their claim, Brendan Reilly said. “Have you seen ‘Westworld?’” Reilly, the company’s CRO, asked as he sat at a…
Wooing a NextGen workforce? Millennials, Gen-Z will turn down jobs missing these 3 elements
Employment is always a give-and-take scenario, said Ross Quinn, but today’s complex NextGen workforce wants more than a paycheck for time spent on the clock. Millennials and Gen-Z workers often won’t feel satisfied with a position or a potential job if they aren’t given significant freedom and trust in exchange for the skill sets and…
With new partner, Firebrand ramps up ‘founder-focused’ culture, aims to double fund
Firebrand Ventures is the right culture fit at the right time, said serial entrepreneur Ryan Merket. Joining the Kansas City-based venture firm as a partner alongside John Fein, Merket brings a wealth of experience from his time at Facebook, Reddit and Amazon, as well as five years as an angel investor, he said. “Looking at…
No Coast winners: Two rapidly growing KC tech startups championed
Tech leadership and innovation know No Coast, said Ryan Weber Friday night as the KC Tech Council revealed its inaugural award show honorees. Beneath the glittering chandeliers of the Abbott luxury event space — and surrounded by elaborate set pieces and balloon art — Weber and the KC Tech Council team announced winners in four No…